Integrated Continuous Biomanufacturing

Integrated Continuous Biomanufacturing is a biopharmaceutical production framework that integrates multiple unit operations into a single, uninterrupted process to enable end-to-end continuous manufacturing of biologics, distinguishing itself from batch or partially continuous methods by its seamless connectivity and real-time control across upstream and downstream stages.

32

Publications

2.1K

Citations

141

Authors

54

Institutions

Publications per year

2017–2026

26

Variants

End-to-end Continuous Biomanufacturing

Authors

141

  1. JW
    Jason Walther

    Sanofi (United States), United States

    3 publications · 711 citations

    4

    h-index

  2. AJ
    Alois Jungbauer

    BOKU University, Austria

    4 publications · 110 citations

    4

    h-index

  3. BN
    Bernt Nilsson

    Lund University, Sweden

    2 publications · 78 citations

    3

    h-index

  4. KB
    Kevin Brower

    Sanofi (United States), United States

    2 publications · 476 citations

    3

    h-index

  5. NA
    Niklas Andersson

    Lund University, Sweden

    2 publications · 78 citations

    3

    h-index

1–5 of 141

Venues

  1. Biotechnology and Bioengineering

    10 publications · 925 citations

    10

    h-index

  2. Biotechnology Progress

    3 publications · 268 citations

    3

    h-index

  3. Biotechnology Journal

    2 publications · 107 citations

    2

    h-index

  4. 2

    h-index

  5. Journal of Chromatography A

    1 publications · 13 citations

    2

    h-index

1–5